•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A10299 Summary:

BILL NOA10299
 
SAME ASNo Same As
 
SPONSORRosenthal L
 
COSPNSR
 
MLTSPNSR
 
Amd 3306, Pub Health L
 
Decriminalizes psilocybin.
Go to top    

A10299 Actions:

BILL NOA10299
 
04/15/2020referred to health
Go to top

A10299 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A10299
 
SPONSOR: Rosenthal L
  TITLE OF BILL: An act to amend the public health law, in relation to decriminalizing psilocybin   PURPOSE: This legislation will decriminalize psilocybin.   SUMMARY OF SPECIFIC PROVISIONS: Section one amends paragraphs 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 and 38 of subdivision (d) of schedule I of section 3306 of the public health law, paragraphs 19, 20, 21, 22, 23, and 24 as added by chapter 664 of the laws of 1985, paragraphs 25, 26, 27, 28, 29, and 30 as added by chapter 589 of the laws of 1996, paragraphs 31 and 32 as added by chapter 457 of the laws of 2006, para- graphs 33, 34 and 35 as added by chapter 370 of the laws of 2015 and paragraphs 36, 37 and 38 as added by section 5 of part BB of chapter 57 and the laws of 2018. Section two establishes the effective date.   JUSTIFICATION: Psilocybin is a naturally occurring chemical compound produced by certain species of mushroom. It is the active ingredient in what are colloquially called "magic mushrooms." In 2018,the United States Food and Drug Administration designated the use of psilocybin as a "break- through therapy for treatment-resistant depression," after reviewing the work of Compass Pathways, which is conducting clinical trials exploring its use in treating severe depression. One study demonstrated that a single dose of psilocybin could assist cancer patients in combating anxiety and dark moods, while others indicated the drug's ability to help people struggling with substance use disorder, addiction to nico- tine and anorexia nervosa. Many cities, including Denver, CO, Santa Cruz, CA, and Oakland, CA, have already decriminalized the use and possession of psilocybin, and New York should do the same. With the opportunity to positively affect the lives of millions suffering with mental health and addiction issues, this bill will decriminalize psilo- cybin and allow further research into the study of the drug and its beneficial uses for treatment.   LEGISLATIVE HISTORY: New bill.   FISCAL IMPLICATIONS: Undetermined.   EFFECTIVE DATE: This bill shall take effect on the ninetieth day after it shall have become a law.
Go to top

A10299 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          10299
 
                   IN ASSEMBLY
 
                                     April 15, 2020
                                       ___________
 
        Introduced  by  M.  of  A. L. ROSENTHAL -- read once and referred to the
          Committee on Health
 
        AN ACT to amend the public health law, in  relation  to  decriminalizing
          psilocybin
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Paragraphs 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29,  30,
     2  31,  32,  33,  34, 35, 36, 37 and 38 of subdivision (d) of schedule I of
     3  section 3306 of the public health law, paragraphs 19, 20, 21, 22, 23 and
     4  24 as added by chapter 664 of the laws of 1985, paragraphs 25,  26,  27,
     5  28, 29 and 30 as added by chapter 589 of the laws of 1996, paragraphs 31
     6  and  32  as  added by chapter 457 of the laws of 2006, paragraphs 33, 34
     7  and 35 as added by chapter 370 of the laws of 2015 and paragraphs 36, 37
     8  and 38 as added by section 5 of part BB of chapter 57  of  the  laws  of
     9  2018, are amended to read as follows:
    10    (19) [Psilocybin.
    11    (20)] Psilocyn.
    12    [(21)] (20) Tetrahydrocannabinols.   Synthetic   equivalents   of  the
    13  substances contained in the plant, or in  the  resinous  extractives  of
    14  cannabis,  sp. and/or synthetic substances, derivatives, and their isom-
    15  ers with similar chemical structure and pharmacological activity such as
    16  the following:
    17    [/\] delta 1 cis or  trans  tetrahydrocannabinol,  and  their  optical
    18  isomers
    19    [/\]  delta  6  cis  or  trans tetrahydrocannabinol, and their optical
    20  isomers
    21    [/\] delta 3, 4 cis or trans  tetrahydrocannabinol,  and  its  optical
    22  isomers  (since  nomenclature of these substances is not internationally
    23  standardized, compounds of these  structures,  regardless  of  numerical
    24  designation of atomic positions covered).
    25    [(22)]  (21) Ethylamine  analog of phencyclidine.  Some trade or other
    26  names:   N-ethyl-1-phenylcyclohexylamine,  (1-phenylcyclohexyl)  ethyla-
    27  mine, N-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD14673-01-0

        A. 10299                            2
 
     1    [(23)]  (22) Pyrrolidine analog of phencyclidine.  Some trade or other
     2  names 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy, PHP.
     3    [(24)] (23)  Thiophene  analog of phencyclidine.   Some trade or other
     4  names:    1-{1-(2-thienyl)-cyclohexyl}-piperidine,  2-thienylanalog   of
     5  phencyclidine, TPCP, TCP.
     6    [(25)] (24) 3,4-methylenedioxymethamphetamine (MDMA).
     7    [(26)] (25) 3,4-methylendioxy-N-ethylamphetamine    (also   known   as
     8  N-ethyl-alpha-methyl-3,4 (methylenedioxy)) phenethylamine, N-ethyl  MDA,
     9  MDE, MDEA.
    10    [(27)]  (26) N-hydroxy-3,4-methylenedioxyamphetamine  (also  known  as
    11  N-hydroxy-alpha-methyl-3,4   (methylenedioxy))    phenethylamine,    and
    12  N-hydroxy MDA.
    13    [(28)]  (27) 1-{1- (2-thienyl)  cyclohexyl}  pyrrolidine.  Some  other
    14  names: TCPY.
    15    [(29)]  (28) Alpha-ethyltryptamine.  Some  trade   or   other   names:
    16  etryptamine;         Monase;         Alpha-ethyl-1H-indole-3-ethanamine;
    17  3- (2-aminobutyl) indole; Alpha-ET or AET.
    18    [(30)] (29) 2,5-dimethoxy-4-ethylamphetamine.   Some  trade  or  other
    19  names: DOET.
    20    [(31)]  (30) 4-Bromo-2,5-dimethoxyphenethylamine.  Some trade or other
    21  names:  2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane;   alpha-desmethyl
    22  DOB; 2C-B, Nexus.
    23    [(32)] (31) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its
    24  optical isomers, salts and salts of isomers.
    25    [(33)] (32) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)
    26  ethanamine also known as 25I-NBOMe; 2C-I-NBOMe; 25I; or Cimbi-5.
    27    [(34)] (33) 2-(4-chloro-2,5-dimethoxyphenyl)-N-      (2-methoxybenzyl)
    28  ethanamine, also known as 25 CNBOMe; 2C-C-NBOMe; 25C; or Cimbi-82.
    29    [(35)] (34) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-       methoxybenzyl)
    30  ethanamine, also known as, 25 BNBOMe; 2C-B-NBOMe; Cimbi-36.
    31    [(36)] (35) 5-methoxy-N,N-dimethyltryptamine.
    32    [(37)] (36) Alpha-methyltryptamine. Some trade or other names: AMT.
    33    [(38)] (37) 5-methoxy-N,N-diisopropyltryptamine.  Some  trade or other
    34  names: 5-MeO-DIPT.
    35    § 2. This act shall take effect on the ninetieth day  after  it  shall
    36  have become a law.
Go to top